Purified subfragment encoding neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis

The inventions provides the use of an inactivated avian influenza virus in the preparation of a medicament for protecting against infection with avian influenza virus, wherein the inactivated virus is characterized by the same subtype of viral haemagglutinin and a different subtype of neuraminidase...

Full description

Saved in:
Bibliographic Details
Main Authors STEFANO MARANGON, ILARIA CAPUA, GIOVANNI CATTOLI
Format Patent
LanguageEnglish
Published 07.06.2007
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
TESTING
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The inventions provides the use of an inactivated avian influenza virus in the preparation of a medicament for protecting against infection with avian influenza virus, wherein the inactivated virus is characterized by the same subtype of viral haemagglutinin and a different subtype of neuraminidase compared to the infectious virus against which protection is sought.
Bibliography:Application Number: AU20020253542